Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Renal Failure
  Free Subscription

Articles published in
Nephrol Dial Transplant
    April 2024
  1. LOMBARDI G, Ferraro PM, De Tomi E, Bargagli M, et al
    Sex differences in chronic kidney disease-related complications and mortality across levels of glomerular filtration rate.
    Nephrol Dial Transplant. 2024 Apr 17:gfae087. doi: 10.1093.
    >> Share

  2. ZHANG X, Wang G, Li M, Li Y, et al
    Both partial inactivation as well as activation of NF-kappaB signaling lead to hypertension and chronic kidney disease.
    Nephrol Dial Transplant. 2024 Apr 13:gfae090. doi: 10.1093.
    >> Share


  3. Correction to: Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitis.
    Nephrol Dial Transplant. 2024 Apr 10:gfae073. doi: 10.1093.
    >> Share

  4. STOUMPOS S, Crowe K, Sarafidis P, Barratt J, et al
    Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association.
    Nephrol Dial Transplant. 2024 Apr 4:gfae075. doi: 10.1093.
    >> Share

    March 2024
  5. WINDAHL K, Chesnaye NC, Irving GF, Stenvinkel P, et al
    The safety of a low protein diet in older adults with advanced chronic kidney disease.
    Nephrol Dial Transplant. 2024 Mar 27:gfae077. doi: 10.1093.
    >> Share

  6. FORBES AK, Hinton W, Feher MD, Elson W, et al
    A Comparison of Sodium-Glucose Co-Transporter 2 Inhibitor Kidney Outcome Trial Participants with a Real-World Chronic Kidney Disease Primary Care Population.
    Nephrol Dial Transplant. 2024 Mar 22:gfae071. doi: 10.1093.
    >> Share

  7. VALENZUELA PL, Castillo-Garcia A, Saco-Ledo G, Santos-Lozano A, et al
    Physical exercise: a polypill against chronic kidney disease.
    Nephrol Dial Transplant. 2024 Mar 9:gfae062. doi: 10.1093.
    >> Share

  8. ZHAI S, Liu D, Liu H, Li W, et al
    Cold atmospheric plasma for chronic kidney disease-related skin disorders.
    Nephrol Dial Transplant. 2024 Mar 1:gfae057. doi: 10.1093.
    >> Share

    February 2024
  9. VAN OEVELEN M, Bonenkamp AA, van Eck van der Sluijs A, Bos WJW, et al
    Health-related quality of life and symptom burden in patients on haemodialysis.
    Nephrol Dial Transplant. 2024;39:436-444.
    >> Share

  10. AKERBOOM B, Janse RJ, Caldinelli A, Lindholm B, et al
    A tool to predict the risk of lower extremity amputation in patients starting dialysis.
    Nephrol Dial Transplant. 2024 Feb 26:gfae050. doi: 10.1093.
    >> Share

  11. KUNUTSOR SK, Dey RS, Touw DJ, Bakker SJL, et al
    Urine cotinine versus self-reported smoking and the risk of chronic kidney disease.
    Nephrol Dial Transplant. 2024 Feb 24:gfae054. doi: 10.1093.
    >> Share

  12. VERZOLA D, Saio M, Milanesi S, Picciotto D, et al
    Altered adiponectin regulation in skeletal muscle of patients with chronic kidney disease.
    Nephrol Dial Transplant. 2024 Feb 23:gfae051. doi: 10.1093.
    >> Share

  13. MISTRY K, Zhao S, Strohbehn I, Wang Q, et al
    Acute and chronic kidney function decline in patients receiving BRAF/MEK inhibitors for melanoma.
    Nephrol Dial Transplant. 2024 Feb 22:gfae049. doi: 10.1093.
    >> Share

  14. DUFF R, Awofala O, Arshad MT, Lambourg E, et al
    Global health inequalities of chronic kidney disease: a meta-analysis.
    Nephrol Dial Transplant. 2024 Feb 22:gfae048. doi: 10.1093.
    >> Share

  15. LAVILLE SM, Couchoud C, Bauwens M, Coponat HV, et al
    Effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in patients on chronic dialysis: a nationwide registry study.
    Nephrol Dial Transplant. 2024 Feb 16:gfae042. doi: 10.1093.
    >> Share

  16. ELHAFEEZ SA, Kramer A, Arici M, Arnol M, et al
    Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA Registry.
    Nephrol Dial Transplant. 2024 Feb 7:gfae034. doi: 10.1093.
    >> Share

    January 2024
  17. BAILOOR K, Laventhal N, Heung M, Wright J, et al
    Hemodialysis in non-cooperative patients: a structured approach.
    Nephrol Dial Transplant. 2024 Jan 22:gfae017. doi: 10.1093.
    >> Share

  18. WU IW, Chang LC, Wu YL, Yang HY, et al
    Gut flora metagenomic analysis coupled with metabolic and deep immune profiling in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Jan 19:gfae013. doi: 10.1093.
    >> Share

  19. CHEN Z, Chen C, Lai K, Wu C, et al
    GSDMD and GSDME synergy in the transition of acute kidney injury to chronic kidney disease.
    Nephrol Dial Transplant. 2024 Jan 19:gfae014. doi: 10.1093.
    >> Share

  20. MATUS GONZALEZ A, Evangelidis N, Howell M, Jaure A, et al
    Outcomes for clinical trials involving adults with chronic kidney disease: a multinational Delphi survey involving patients, caregivers, and health professionals.
    Nephrol Dial Transplant. 2024 Jan 17:gfae010. doi: 10.1093.
    >> Share

  21. BADA-BOSCH T, Sevillano AM, Teresa Sanchez-Calvin M, Palma-Milla C, et al
    Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome.
    Nephrol Dial Transplant. 2024 Jan 4:gfae002. doi: 10.1093.
    >> Share

  22. VESTERGAARD AHS, Jensen SK, Heide-Jorgensen U, Frederiksen LE, et al
    Risk factor analysis for a rapid progression of chronic kidney disease.
    Nephrol Dial Transplant. 2024 Jan 2:gfad271. doi: 10.1093.
    >> Share

    December 2023
  23. SAKHI H, Beaumier M, Couchoud C, Prezelin-Reydit M, et al
    Social deprivation and kidney failure due to an undiagnosed nephropathy.
    Nephrol Dial Transplant. 2023;39:133-140.
    >> Share

  24. PISANI A, Pieruzzi F, Cirami CL, Riccio E, et al
    Interpretation of GFR slope in untreated and treated adult Fabry patients.
    Nephrol Dial Transplant. 2023;39:18-25.
    >> Share

  25. TANG C, Chen P, Si FL, Yao YX, et al
    Intensive blood pressure control and the progression of IgA nephropathy: a cohort study using marginal structural models.
    Nephrol Dial Transplant. 2023;39:55-63.
    >> Share

  26. FOUNTOGLOU A, Deltas C, Siomou E, Dounousi E, et al
    Genome-wide association studies reconstructing chronic kidney disease.
    Nephrol Dial Transplant. 2023 Dec 20:gfad209. doi: 10.1093.
    >> Share

  27. BHANDARI S, Mehta S, Ives N, Cockwell P, et al
    Utility of 2-year kidney failure risk equation for advanced chronic kidney disease: analysis from the STOP ACEi Trial.
    Nephrol Dial Transplant. 2023 Dec 19:gfad263. doi: 10.1093.
    >> Share

    November 2023
  28. WANG M, Xiao J, Du Q, Zhang W, et al
    Phosphorus balance calculator: an individualized tool for treatment of hyperphosphatemia in hemodialysis patients.
    Nephrol Dial Transplant. 2023 Nov 30:gfad256. doi: 10.1093.
    >> Share

  29. BROOKS ER, Siriruchatanon M, Prabhu V, Charytan DM, et al
    Chronic kidney disease and risk of kidney or urothelial malignancy: systematic review and meta-analysis.
    Nephrol Dial Transplant. 2023 Nov 30:gfad249. doi: 10.1093.
    >> Share


  30. Correction to: The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.
    Nephrol Dial Transplant. 2023 Nov 30:gfad252. doi: 10.1093.
    >> Share

  31. BHASIN AA, Molnar AO, McArthur E, Nash DM, et al
    Mental health and addiction service utilization among people living with chronic kidney disease.
    Nephrol Dial Transplant. 2023 Nov 28:gfad240. doi: 10.1093.
    >> Share

  32. ALENCAR DE PINHO N, Prezelin-Reydit M, Harambat J, Couchoud C, et al
    Arteriovenous access creation and hazards of hospitalization and death in patients starting hemodialysis.
    Nephrol Dial Transplant. 2023 Nov 27:gfad251. doi: 10.1093.
    >> Share

  33. GOTO H, Iseri K, Hida N
    Fibrates and the risk of cardiovascular outcomes in chronic kidney disease patients.
    Nephrol Dial Transplant. 2023 Nov 27:gfad248. doi: 10.1093.
    >> Share

  34. LEVASSORT H, Boucquemont J, de Pinho NA, Lambert O, et al
    A New Approach for Cognitive Impairment Pattern in Chronic Kidney Disease.
    Nephrol Dial Transplant. 2023 Nov 9:gfad244. doi: 10.1093.
    >> Share

  35. HARDING JL, Di M, Pastan SO, Doucet N, et al
    Examination of Sex/Gender Disparities Across the Continuum of Kidney Transplant Steps.
    Nephrol Dial Transplant. 2023 Nov 9:gfad242. doi: 10.1093.
    >> Share

  36. STEFAN G, Jullien P, Masson I, Alamartine E, et al
    Circulating alternative pathway complement cleavage factor Bb is associated with vascular lesions and outcomes in IgA nephropathy.
    Nephrol Dial Transplant. 2023;38.
    >> Share

  37. KIM HW, Heo GY, Kim HJ, Kang SW, et al
    Insomnia in patients on incident maintenance dialysis and the risk of major acute cardio-cerebrovascular events and all-cause mortality.
    Nephrol Dial Transplant. 2023 Nov 3:gfad231. doi: 10.1093.
    >> Share

  38. LE GALL L, Harambat J, Combe C, Philipps V, et al
    Haemoglobin trajectories in chronic kidney disease and risk of major adverse cardiovascular events.
    Nephrol Dial Transplant. 2023 Nov 3:gfad235. doi: 10.1093.
    >> Share

    October 2023
  39. TULLUS K
    Why FSGS keeps being presented as a disease although it is not.
    Nephrol Dial Transplant. 2023;38:2426-2427.
    >> Share

  40. ZENG M, Di H, Liang J, Liu Z, et al
    Effectiveness of renin-angiotensin-aldosterone system blockers in patients with Alport syndrome: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2023;38:2485-2493.
    >> Share

  41. CASAL MOURA M, Gauckler P, Anders HJ, Bruchfeld A, et al
    Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations.
    Nephrol Dial Transplant. 2023;38:2637-2651.
    >> Share

  42. HAMROUN A, Glowacki F, Frimat L
    Comprehensive conservative care: what doctors say, what patients hear.
    Nephrol Dial Transplant. 2023;38:2428-2443.
    >> Share

  43. GRITTER M, Wei KY, Wouda RD, Musterd-Bhaggoe UM, et al
    Chronic kidney disease increases the susceptibility to negative effects of low and high potassium intake.
    Nephrol Dial Transplant. 2023 Oct 9:gfad220. doi: 10.1093.
    >> Share

  44. PUURUNEN M, Kurtz C, Wheeler A, Mulder K, et al
    24-hour urine oxalate and risk of chronic kidney disease.
    Nephrol Dial Transplant. 2023 Oct 6:gfad221. doi: 10.1093.
    >> Share

  45. KANG SY, Lee YH, Jeong SJ, Kim JS, et al
    How obesity and metabolic syndrome affect cardiovascular events, progression to kidney failure and all-cause mortality in chronic kidney disease.
    Nephrol Dial Transplant. 2023 Oct 3:gfad214. doi: 10.1093.
    >> Share

  46. MAKHAMMAJANOV Z, Gaipov A, Myngbay A, Bukasov R, et al
    Tubular toxicity of proteinuria and the progression of chronic kidney disease.
    Nephrol Dial Transplant. 2023 Oct 3:gfad215. doi: 10.1093.
    >> Share

    September 2023
  47. BON G, Jullien P, Masson I, Sauron C, et al
    Validation of the international IgA nephropathy prediction tool in a French cohort beyond 10 years after diagnosis.
    Nephrol Dial Transplant. 2023;38:2257-2265.
    >> Share

  48. DEL VECCHIO L, Balafa O, Dounousi E, Ekart R, et al
    COVID-19 and cardiovascular disease in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2023 Sep 28:gfad170. doi: 10.1093.
    >> Share

  49. CASINO FG, Roblero MFS, Gonzalez-Sanchidrian S, Dominguez SG, et al
    Prescribing the dialysis dose and treatment frequency in home haemodialysis.
    Nephrol Dial Transplant. 2023 Sep 26:gfad212. doi: 10.1093.
    >> Share

  50. KIM H, Hyun YY, Joo YS, Yun HR, et al
    Proteinuria, measured or estimated albuminuria for risk prediction in patients with chronic kidney disease?
    Nephrol Dial Transplant. 2023 Sep 18:gfad195. doi: 10.1093.
    >> Share

  51. FERRARO PM, D'Ambrosio V, Gambaro G, Giachino D, et al
    A clinical screening algorithm for primary hyperoxaluria type 1 in adults on dialysis.
    Nephrol Dial Transplant. 2023 Sep 14:gfad184. doi: 10.1093.
    >> Share

  52. WALLER M, Krenn S, Mussnig S, Schmiedecker M, et al
    Bioimpedance-derived euvolemic weight varies in hemodialysis patients - challenging the fixed target weight concept.
    Nephrol Dial Transplant. 2023 Sep 14:gfad206. doi: 10.1093.
    >> Share

  53. EVENEPOEL P, Jorgensen HS, Bover J, Davenport A, et al
    Recommended calcium intake in adults and children with chronic kidney disease - a European consensus statement.
    Nephrol Dial Transplant. 2023 Sep 11:gfad185. doi: 10.1093.
    >> Share

  54. MAVROGEORGIS E, He T, Mischak H, Latosinska A, et al
    Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease.
    Nephrol Dial Transplant. 2023 Sep 11:gfad200. doi: 10.1093.
    >> Share

  55. TORINO C, Mallamaci F, Sarafidis P, Papagianni A, et al
    The long-term effect of a lung-ultrasound intervention on the risk for death, heart failure and myocardial infarction in dialysis patients.
    Nephrol Dial Transplant. 2023 Sep 7:gfad187. doi: 10.1093.
    >> Share

  56. JONGEJAN M, de Lange S, Bos WJW, Pieterse AH, et al
    Choosing Conservative Care in Advanced Chronic Kidney Disease - Patients' Perspectives.
    Nephrol Dial Transplant. 2023 Sep 5:gfad196. doi: 10.1093.
    >> Share

  57. BARRERA-BAENA P, Rodriguez-Garcia M, Rodriguez-Rubio E, Gonzalez-Llorente L, et al
    Serum phosphate is associated with increased risk of bone fragility fractures in hemodialysis patients.
    Nephrol Dial Transplant. 2023 Sep 2:gfad190. doi: 10.1093.
    >> Share

    August 2023
  58. HEERSPINK HJL, Greasley PJ, Ahlstrom C, Althage M, et al
    Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial.
    Nephrol Dial Transplant. 2023 Aug 25:gfad183. doi: 10.1093.
    >> Share

  59. RASHIDI MM, Moghaddam SS, Azadnajafabad S, Heidari-Foroozan M, et al
    Burden and quality of care index of chronic kidney disease: Global Burden of Disease analysis for 1990-2019.
    Nephrol Dial Transplant. 2023 Aug 16:gfad172. doi: 10.1093.
    >> Share

  60. ZOCCALI C, Manfredini F, Kanbay M, Mallamaci F, et al
    Intradialysis Exercise in Hemodialysis Patients: Effective But Complex and Costly.
    Nephrol Dial Transplant. 2023 Aug 10:gfad178. doi: 10.1093.
    >> Share

    July 2023
  61. XU X, Yang Z, Li S, Pei H, et al
    Cut-off values of hemoglobin and clinical outcomes in incident peritoneal dialysis: the PDTAP study.
    Nephrol Dial Transplant. 2023 Jul 17:gfad166. doi: 10.1093.
    >> Share

  62. KOJIMA S, Usui N, Shigetake M, Uehata A, et al
    Intramuscular and abdominal fat measured by computed tomography and mortality of hemodialysis patients.
    Nephrol Dial Transplant. 2023 Jul 17:gfad169. doi: 10.1093.
    >> Share

  63. WIJKSTROM J, Caldinelli A, Bruchfeld A, Nowak A, et al
    Results of the first nationwide cohort study of outcomes in dialysis and kidney transplant patients before and after vaccination for COVID-19.
    Nephrol Dial Transplant. 2023 Jul 11:gfad151. doi: 10.1093.
    >> Share

  64. ROJAS-RIVERA JE, Bakkaloglu SA, Bolignano D, Nistor I, et al
    Chronic kidney disease: the missing concept in the 2019 EULAR/ERA-EDTA recommendations for lupus nephritis.
    Nephrol Dial Transplant. 2023 Jul 11:gfad154. doi: 10.1093.
    >> Share

  65. GULLAPUDI VRL, Cox EF, Buchanan CE, Canaud B, et al
    Randomised trial comparing standard versus thermocontrolled haemodialysis using intradialytic cardiac, brain and renal magnetic resonance imaging.
    Nephrol Dial Transplant. 2023 Jul 11:gfad150. doi: 10.1093.
    >> Share

  66. CHEN JHC, Johnson DW, Cho Y, Cheetham M, et al
    Associations of neutral pH, low GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis, and peritonitis.
    Nephrol Dial Transplant. 2023 Jul 10:gfad153. doi: 10.1093.
    >> Share

  67. ENGLER F, Kerschbaum J, Keller F, Mayer G, et al
    Prevalence, patient burden and physicians' perception of pruritus in hemodialysis patients.
    Nephrol Dial Transplant. 2023 Jul 10:gfad152. doi: 10.1093.
    >> Share


  68. Correction to: #3739 Shunt portosystemic complicated by hyperammonemia and hepatic encephalopathy supported by daily dialysis in a chronic hemodialysis patient.
    Nephrol Dial Transplant. 2023 Jul 4:gfad141. doi: 10.1093.
    >> Share

  69. GEROLDINGER A, Strohmaier S, Kammer M, Wallisch C, et al
    Sex differences in the survival benefit of kidney transplantation: a retrospective cohort study using target trial emulation.
    Nephrol Dial Transplant. 2023 Jul 4:gfad137. doi: 10.1093.
    >> Share

    June 2023
  70. ZHANG H, Wang LC, Chaudhuri S, Pickering A, et al
    Real-time prediction of intradialytic hypotension using machine learning and cloud computing infrastructure.
    Nephrol Dial Transplant. 2023;38:1761-1769.
    >> Share

  71. STUMPF J, Thomusch O, Opgenoorth M, Wiesener M, et al
    Excellent efficacy and beneficial safety during observational five year follow-up of Rapid Steroid withdrawal after renal transplantation (Harmony FU study).
    Nephrol Dial Transplant. 2023 Jun 30:gfad130. doi: 10.1093.
    >> Share

  72. VILLAIN C, Wagner S, Koppe L
    Elderly patients with chronic kidney disease: towards a better control of protein intake.
    Nephrol Dial Transplant. 2023 Jun 28:gfad129. doi: 10.1093.
    >> Share

  73. KANBAY M, Copur S, Yildiz AB, Covic A, et al
    Intrauterine life to adulthood: a potential risk factor for chronic kidney disease.
    Nephrol Dial Transplant. 2023 Jun 27:gfad134. doi: 10.1093.
    >> Share

  74. GEORGIANOS PI, Agarwal R
    Hypertension in chronic kidney disease - treatment standard 2023.
    Nephrol Dial Transplant. 2023 Jun 24:gfad118. doi: 10.1093.
    >> Share

  75. ATAKA E, Matsukuma Y, Ueki K, Tsuchimoto A, et al
    Cumulative smoking dose is associated with subclinical renal injury: a Pathological study in individuals without chronic kidney disease.
    Nephrol Dial Transplant. 2023 Jun 24:gfad124. doi: 10.1093.
    >> Share

  76. PAWLOWICZ-SZLARSKA E, Vanholder R, Sever MS, Tuglular S, et al
    Distribution, preparedness and management of Ukrainian adult refugees on dialysis-an international survey by the Renal Disaster Relief Task Force of the European Renal Association.
    Nephrol Dial Transplant. 2023 Jun 16:gfad073. doi: 10.1093.
    >> Share

    May 2023
  77. YOSHIKOSHI S, Yamamoto S, Suzuki Y, Imamura K, et al
    Reserved gait capacity and mortality among patients undergoing hemodialysis.
    Nephrol Dial Transplant. 2023 May 31:gfad109. doi: 10.1093.
    >> Share

  78. CANDELLIER A, Bohbot Y, Pasquet A, Diouf M, et al
    Chronic kidney disease is a key risk factor for aortic stenosis progression.
    Nephrol Dial Transplant. 2023 May 29:gfad116. doi: 10.1093.
    >> Share

  79. AU AYM, Mantik K, Bahadory F, Stathakis P, et al
    Plasma arginine metabolites in health and chronic kidney disease.
    Nephrol Dial Transplant. 2023 May 25:gfad108. doi: 10.1093.
    >> Share

  80. TAAL MW, Lucas B, Roderick P, Cockwell P, et al
    Associations with age and glomerular filtration rate in a referred population with chronic kidney disease: Methods and baseline data from a UK multicentre cohort study (NURTuRE-CKD).
    Nephrol Dial Transplant. 2023 May 25:gfad110. doi: 10.1093.
    >> Share

  81. SCHRAUBEN SJ, Sapa H, Xie D, Zhang X, et al
    Association of urine and plasma ADMA with atherosclerotic cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Nephrol Dial Transplant. 2023 May 25:gfad103. doi: 10.1093.
    >> Share

  82. MARK PB, Sarafidis P, Ekart R, Ferro CJ, et al
    SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA.
    Nephrol Dial Transplant. 2023 May 25:gfad112. doi: 10.1093.
    >> Share

  83. KOLBRINK B, Schussel K, von Samson-Himmelstjerna FA, Esser G, et al
    Patient-focused outcomes after initiation of dialysis for ESRD: mortality, hospitalization, and functional impairment.
    Nephrol Dial Transplant. 2023 May 18:gfad099. doi: 10.1093.
    >> Share

  84. BATTAGLIA Y, Amicone M, Mantovani A, Combe C, et al
    Home-based exercise in patients on maintenance dialysis: a systematic review and meta-analysis of randomized clinical trials.
    Nephrol Dial Transplant. 2023 May 18:gfad102. doi: 10.1093.
    >> Share

  85. HASEGAWA T, Imaizumi T, Hamano T, Murotani K, et al
    Association between serum iron markers, iron supplementation, and cardiovascular morbidity in pre-dialysis chronic kidney disease.
    Nephrol Dial Transplant. 2023 May 18:gfad096. doi: 10.1093.
    >> Share

  86. LU J, Li H, Wang S
    Interaction effect of psoriasis and chronic kidney disease on the risk of all-cause mortality: a prospective cohort study of NHANES data.
    Nephrol Dial Transplant. 2023 May 12:gfad089. doi: 10.1093.
    >> Share

  87. PEYRO-SAINT-PAUL L, Bechade C, Cesbron A, Debruyne D, et al
    Effect of Peritoneal Dialysis in End Stage Renal Disease on Apixaban Pharmacokinetics.
    Nephrol Dial Transplant. 2023 May 11:gfad087. doi: 10.1093.
    >> Share

  88. GITTUS M, Bailey PK, Griffin S
    Management of Patients with a Failing Kidney Transplant: a Survey of Uk-Based Renal Units.
    Nephrol Dial Transplant. 2023 May 11:gfad084. doi: 10.1093.
    >> Share

  89. NANGAKU M, Takama H, Ichikawa T, Mukai K, et al
    Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study.
    Nephrol Dial Transplant. 2023;38:1204-1216.
    >> Share

  90. HAASKJOLD YL, Lura NG, Bjorneklett R, Bostad L, et al
    Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up.
    Nephrol Dial Transplant. 2023;38:1183-1191.
    >> Share

    April 2023
  91. FERRARI F, Andrade FP, Teixeira MS, Ziegelmann PK, et al
    Efficacy of six exercise-based interventions for individuals undergoing hemodialysis: a network meta-analysis of randomized clinical trials.
    Nephrol Dial Transplant. 2023 Apr 28:gfad083. doi: 10.1093.
    >> Share

  92. SARNAK MJ, Agarwal R, Boudville N, Chowdhury PCP, et al
    Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis.
    Nephrol Dial Transplant. 2023 Apr 24:gfad074. doi: 10.1093.
    >> Share

  93. FAIVRE A, Dissard R, Kuo W, Verissimo T, et al
    Evolution of hypoxia and hypoxia-inducible factor asparaginyl hydroxylase (FIH) regulation in chronic kidney disease.
    Nephrol Dial Transplant. 2023 Apr 24:gfad075. doi: 10.1093.
    >> Share

  94. THEODORAKOPOULOU MP, Dipla K, Zafeiridis A, Faitatzidou D, et al
    Cerebral oxygenation during exercise deteriorates with advancing chronic kidney disease.
    Nephrol Dial Transplant. 2023 Apr 24:gfad076. doi: 10.1093.
    >> Share

  95. SIRKEOJA S, Honkanen M, Huttunen R, Makela S, et al
    The evaluation of penicillin allergy in dialysis patients.
    Nephrol Dial Transplant. 2023 Apr 17:gfad072. doi: 10.1093.
    >> Share

  96. JUDGE PK, Herrington WG, Haynes R
    Sacubitril/valsartan in peritoneal dialysis - lessons from a pharmacokinetic study.
    Nephrol Dial Transplant. 2023 Apr 10:gfad066. doi: 10.1093.
    >> Share

  97. LEE H, Moon SJ, Kim SW, Min JW, et al
    Prediction of intradialytic hypotension using pre-dialysis features - a deep learning-based artificial intelligence model.
    Nephrol Dial Transplant. 2023 Apr 5:gfad064. doi: 10.1093.
    >> Share

    March 2023
  98. YAMAGATA K
    Trends in the incidence of kidney replacement therapy: comparisons of ERA, USRDS and Japan registries.
    Nephrol Dial Transplant. 2023;38:797-799.
    >> Share

  99. PEREZ-ARIAS AA, Marquez-Macedo SE, Pena-Vizcarra OR, Zavala-Miranda MF, et al
    The influence of repeated flares in response to therapy and prognosis in lupus nephritis.
    Nephrol Dial Transplant. 2023;38:884-893.
    >> Share

  100. HUIJBEN JA, Kramer A, Kerschbaum J, de Meester J, et al
    Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: an ERA Registry study.
    Nephrol Dial Transplant. 2023;38:1027-1040.
    >> Share

  101. MEHTA S, Lightle A, Judson MA
    Renal sarcoidosis.
    Nephrol Dial Transplant. 2023;38:803-810.
    >> Share

  102. CHO WJ, Harden D, Moreno D, Dinulos JE, et al
    Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure.
    Nephrol Dial Transplant. 2023 Mar 22:gfad058. doi: 10.1093.
    >> Share

  103. DE BORST MH, Carrero JJ
    Will osteopontin bridge the gap towards clinical application in chronic kidney disease?
    Nephrol Dial Transplant. 2023 Mar 20:gfad057. doi: 10.1093.
    >> Share

  104. SYMONIDES B, Lewandowski J, Malyszko J
    Resistant hypertension in dialysis.
    Nephrol Dial Transplant. 2023 Mar 10:gfad047. doi: 10.1093.
    >> Share

  105. METRY EL, Garrelfs SF, Peters-Sengers H, Vaz FM, et al
    Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1.
    Nephrol Dial Transplant. 2023 Mar 10:gfad049. doi: 10.1093.
    >> Share

  106. WANG AY, Lo WK, Cheung SC, Tang TK, et al
    Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): A randomized trial.
    Nephrol Dial Transplant. 2023 Mar 3:gfad043. doi: 10.1093.
    >> Share

  107. PINTER J, Genser B, Moissl U, Stuard S, et al
    Hyponatraemia and fluid overload are associated with higher risk of mortality in dialysis patients.
    Nephrol Dial Transplant. 2023 Mar 1:gfad041. doi: 10.1093.
    >> Share

    February 2023
  108. WEIR MA, Walsh M, Cuerden MS, Sontrop JM, et al
    The effect of micro-particle curcumin on chronic kidney disease progression: the MPAC-CKD randomized clinical trial.
    Nephrol Dial Transplant. 2023 Feb 27:gfad037. doi: 10.1093.
    >> Share

  109. BORRELLI S, Garofalo C, Gabbai FB, Liberti ME, et al
    Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies.
    Nephrol Dial Transplant. 2023 Feb 16:gfad036. doi: 10.1093.
    >> Share

  110. HE Y, Jin Y, Xue H, Liu R, et al
    Pharmacokinetics and pharmacodynamics of sacubitril/valsartan in peritoneal dialysis patients.
    Nephrol Dial Transplant. 2023 Feb 14:gfad038. doi: 10.1093.
    >> Share

  111. LINDHARD K, Jensen BL, Pedersen BL, Meyer-Olesen C, et al
    Far infrared treatment on the arteriovenous fistula induces changes in sVCAM and sICAM in patients on hemodialysis.
    Nephrol Dial Transplant. 2023 Feb 9:gfad032. doi: 10.1093.
    >> Share

  112. ZHANG C, Bartosova M, Marinovic I, Schwab C, et al
    Peritoneal transformation shortly after kidney transplantation in pediatric patients with preceding chronic peritoneal dialysis.
    Nephrol Dial Transplant. 2023 Feb 8:gfad031. doi: 10.1093.
    >> Share

    January 2023
  113. MURASHIMA M, Hamano T, Abe M, Masakane I, et al
    Comparable outcomes between a combination of peritoneal dialysis with once-weekly hemodialysis and thrice-weekly hemodialysis: a prospective cohort study.
    Nephrol Dial Transplant. 2023 Jan 25:gfad019. doi: 10.1093.
    >> Share


  114. Correction to: Patient views regarding cannabis use in chronic kidney disease and kidney failure: a survey study.
    Nephrol Dial Transplant. 2023 Jan 24:gfad012. doi: 10.1093.
    >> Share

  115. PICCOLI GB, Chatrenet A, Cataldo M, Torreggiani M, et al
    Adding creatinine to routine pregnancy tests: a decision tree for calculating the cost of identifying patients with CKD in pregnancy.
    Nephrol Dial Transplant. 2023;38:148-157.
    >> Share

  116. CHENG Y, Xiang Q, Cao T, Tang F, et al
    Suppression of thyroid profile during roxadustat treatment in chronic kidney disease patients.
    Nephrol Dial Transplant. 2023 Jan 20:gfad017. doi: 10.1093.
    >> Share

  117. ROSSING P, Baeres FMM, Bakris G, Bosch-Traberg H, et al
    The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.
    Nephrol Dial Transplant. 2023 Jan 18:gfad009. doi: 10.1093.
    >> Share

  118. ZOCCALI C, Tripepi G, Neri L, Savoia M, et al
    Effectiveness of Cold Hemodialysis (HD) for the Prevention of HD Hypotension and Mortality in the General HD Population.
    Nephrol Dial Transplant. 2023 Jan 17:gfad003. doi: 10.1093.
    >> Share

    December 2022
  119. LENGTON R, van der Willik EM, de Rooij ENM, Meuleman Y, et al
    Effect of residual kidney function and dialysis adequacy on chronic pruritus in dialysis patients.
    Nephrol Dial Transplant. 2022 Dec 22:gfac341. doi: 10.1093.
    >> Share

  120. FARISCO M, Zecchino I, Capasso G
    The need for a multi-disciplinary reflection about frailty and cognitive impairment in chronic kidney disease.
    Nephrol Dial Transplant. 2022 Dec 22:gfac334. doi: 10.1093.
    >> Share

  121. AGARWAL R, Fouque D
    The foundation and the four pillars of treatment for cardiorenal protection in people with chronic kidney disease and type 2 diabetes.
    Nephrol Dial Transplant. 2022 Dec 19:gfac331. doi: 10.1093.
    >> Share

  122. WARSAME F, Chu NM, Hong J, Mathur A, et al
    Sleep duration and cognitive function among older adults with chronic kidney disease - results from the National Health and Nutrition Examination Survey (2011-2014).
    Nephrol Dial Transplant. 2022 Dec 19:gfac325. doi: 10.1093.
    >> Share

  123. DUNG TNT, Balezeaux M, Granal M, Fouque D, et al
    Prediction of all-cause mortality for chronic kidney disease patients using four models of machine learnings.
    Nephrol Dial Transplant. 2022 Dec 9:gfac316. doi: 10.1093.
    >> Share

  124. NOPP S, Konigsbrugge O, Schmaldienst S, Klauser-Braun R, et al
    Growth differentiation factor-15 (GDF-15) predicts major bleeding, major adverse cardiac events, and mortality in patients with end-stage kidney disease on hemodialysis: findings from the VIVALDI study.
    Nephrol Dial Transplant. 2022 Dec 6:gfac321. doi: 10.1093.
    >> Share

  125. LO KB, Rangaswami J, Vaduganathan M
    Nonsteroidal mineralocorticoid receptor antagonists and cardiorenal outcomes in chronic kidney disease.
    Nephrol Dial Transplant. 2022 Dec 6:gfac322. doi: 10.1093.
    >> Share

  126. LEVY-SCHOUSBOE K, Marckmann P, Frimodt-Moller M, Peters CD, et al
    Vitamin K supplementation and bone mineral density in dialysis: results of the double-blind, randomised, placebo-controlled RenaKvit trial.
    Nephrol Dial Transplant. 2022 Dec 2:gfac315. doi: 10.1093.
    >> Share

    November 2022
  127. BONIFANT G, Weir MR
    The role of blood pressure control in the prevention of cardiorenal disease in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2022 Nov 30:gfac313. doi: 10.1093.
    >> Share

  128. HALIMI JM, de Freminville JB, Gatault P, Bisson A, et al
    Long-term impact of cardiorenal syndromes on major outcomes based on their chronology: a comprehensive French nationwide cohort study.
    Nephrol Dial Transplant. 2022;37:2386-2397.
    >> Share

  129. BOECKHAUS J, Hoefele J, Riedhammer KM, Nagel M, et al
    Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study.
    Nephrol Dial Transplant. 2022;37:2496-2504.
    >> Share

  130. YU B, Shi S, Lv J, Liu L, et al
    Rapidly progressive IgA nephropathy: clinicopathological characteristics and outcomes assessed according to the revised definition of the KDIGO 2021 Guideline.
    Nephrol Dial Transplant. 2022;37:2429-2437.
    >> Share

  131. DI H, Zhang J, Gao E, Zheng C, et al
    Dissecting the genotype-phenotype correlation of COL4A5 gene mutation and its response to renin-angiotensin-aldosterone system blockers in Chinese male patients with Alport syndrome.
    Nephrol Dial Transplant. 2022;37:2487-2495.
    >> Share

  132. PELLA E, Boutou A, Boulmpou A, Papadopoulos CE, et al
    Cardiopulmonary exercise testing in patients with end-stage kidney disease: principles, methodology and clinical applications of the optimal tool for exercise tolerance evaluation.
    Nephrol Dial Transplant. 2022;37:2335-2350.
    >> Share

  133. MATHUR VS, Bushinsky DA, Inker L, Klaerner G, et al
    Design and Population of the VALOR-CKD Study: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating the Efficacy and Safety of Veverimer in Slowing Progression of Chronic Kidney Disease in Patients with Metabolic Acidosis.
    Nephrol Dial Transplant. 2022 Nov 4. pii: 6776172. doi: 10.1093.
    >> Share

  134. PORRINI E, Perez NM, Diaz JM, Lauzurrica R, et al
    Post-transplant diabetes mellitus and renal cell cancer after renal transplantation.
    Nephrol Dial Transplant. 2022 Nov 2. pii: 6794278. doi: 10.1093.
    >> Share

  135. GREINERT R, Greinert D, Eger AL, Ripoll C, et al
    Subclinical cognitive impairment in chronic kidney disease is associated with frailty and reduced quality of life.
    Nephrol Dial Transplant. 2022 Nov 2. pii: 6794277. doi: 10.1093.
    >> Share

    October 2022
  136. HUNDEMER GL, Ravani P, Sood MM, Zimmerman D, et al
    Social determinants of health and the transition from advanced chronic kidney disease to kidney failure.
    Nephrol Dial Transplant. 2022 Oct 31. pii: 6783171. doi: 10.1093.
    >> Share

  137. HOSHINO J, Abe M, Hamano T, Hasegawa T, et al
    Glycated albumin to glycated hemoglobin ratio and mortality in diabetic patients on dialysis: a new association.
    Nephrol Dial Transplant. 2022 Oct 29. pii: 6780212. doi: 10.1093.
    >> Share

  138. NEE R, Yuan CM, Narva AS, Yan G, et al
    Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease.
    Nephrol Dial Transplant. 2022 Oct 20. pii: 6764731. doi: 10.1093.
    >> Share

  139. CARRIAZO S, Aparicio-Madre MI, Tornero-Molina F, Fernandez-Lucas M, et al
    Impact of different COVID-19 waves on kidney replacement therapy epidemiology and mortality: REMER 2020.
    Nephrol Dial Transplant. 2022;37:2253-2263.
    >> Share

  140. MATHUR A, Ahn JB, Sutton W, Chu NM, et al
    Secondary hyperparathyroidism (CKD-MBD) treatment and the risk of dementia.
    Nephrol Dial Transplant. 2022;37:2111-2118.
    >> Share

  141. WANG Z, Jiang Y, Chen P, Wang J, et al
    The level of urinary C4d is associated with disease progression in IgA nephropathy with glomerular crescentic lesions: a cohort study.
    Nephrol Dial Transplant. 2022;37:2119-2127.
    >> Share

  142. LINDEBOOM L, Lee S, Wieringa F, Groenendaal W, et al
    On the potential of wearable bioimpedance for longitudinal fluid monitoring in end-stage kidney disease.
    Nephrol Dial Transplant. 2022;37:2048-2054.
    >> Share

  143. MIYAMOTO Y, Katagiri R, Yamaji T, Inoue M, et al
    Association of chronic kidney disease with total and site-specific cancer incidence in participants of the Japan Public Health Center-based Prospective Study.
    Nephrol Dial Transplant. 2022 Oct 16. pii: 6761705. doi: 10.1093.
    >> Share

  144. DUONG MD, Wang S, Schwartz D, Mowrey WB, et al
    Total cortical interstitial inflammation predicts chronic kidney disease progression in patients with lupus nephritis.
    Nephrol Dial Transplant. 2022 Oct 11. pii: 6758516. doi: 10.1093.
    >> Share

  145. ORTIZ A, Wanner C, Gansevoort R
    Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association.
    Nephrol Dial Transplant. 2022 Oct 11. pii: 6752463. doi: 10.1093.
    >> Share

  146. BASILE C, Casino FG, Mitra S
    Towards a tailored prescription of dialysis adequacy: the key role of incremental hemodialysis.
    Nephrol Dial Transplant. 2022 Oct 7. pii: 6753234. doi: 10.1093.
    >> Share

    September 2022
  147. NILSSON E, Stenvinkel P, Liu S, Stedman MR, et al
    Testosterone concentrations andoutcomes in hemodialysis patients of the EVOLVE trial.
    Nephrol Dial Transplant. 2022 Sep 29. pii: 6731668. doi: 10.1093.
    >> Share

  148. BENECH N, Koppe L
    Is there a place for fecal microbiota transplantation in chronic kidney disease?
    Nephrol Dial Transplant. 2022 Sep 26. pii: 6717772. doi: 10.1093.
    >> Share

  149. CAI X, Thorand B, Hohenester S, Koenig W, et al
    Association between the fatty liver index and chronic kidney disease: the population-based KORA study.
    Nephrol Dial Transplant. 2022 Sep 23. pii: 6712706. doi: 10.1093.
    >> Share

  150. KRON S, Schneditz D, Kron J
    The blood to extracellular volume relationship is stable and in the physiologic range in chronic haemodialysis patients.
    Nephrol Dial Transplant. 2022;37:2034-2036.
    >> Share

  151. LOMONTE C, Basile C
    What the seminal experience of the Seattle Northwest Kidney Centers teaches to today's young nephrologists.
    Nephrol Dial Transplant. 2022;37:1789-1791.
    >> Share

  152. DE JONG RW, Boezeman EJ, Chesnaye NC, Bemelman FJ, et al
    Work status and work ability of patients receiving kidney replacement therapy: results from a European survey.
    Nephrol Dial Transplant. 2022;37:2022-2033.
    >> Share

  153. MARTIN KJ
    How to evaluate phosphate control in patients on dialysis.
    Nephrol Dial Transplant. 2022;37:1830-1832.
    >> Share

  154. FORTE V, Novelli S, Zaidan M, Snanoudj R, et al
    Microbiology and outcomes of polymicrobial peritonitis associated with peritoneal dialysis: a register-based cohort study from the French Language Peritoneal Dialysis Registry (RDPLF).
    Nephrol Dial Transplant. 2022 Sep 21. pii: 6710379. doi: 10.1093.
    >> Share

  155. CHEN HJ, Qiu J, Qi Y, Fu L, et al
    Hippocampal subfield morphology in regular hemodialysis patients.
    Nephrol Dial Transplant. 2022 Sep 17. pii: 6702744. doi: 10.1093.
    >> Share

  156. THIEM U, Hewitson TD, Toussaint ND, Holt SG, et al
    Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells.
    Nephrol Dial Transplant. 2022 Sep 15. pii: 6701380. doi: 10.1093.
    >> Share

  157. KIM Y, Kang J, Chang Y, Hyun YY, et al
    Coronary artery calcium and risk of chronic kidney disease in young and middle-aged adults.
    Nephrol Dial Transplant. 2022 Sep 15. pii: 6701379. doi: 10.1093.
    >> Share

  158. YAMAGUCHI T, Yabe H, Kono K, Moriyama Y, et al
    Factors associated with dropout from an intradialytic exercise program among patients undergoing maintenance hemodialysis.
    Nephrol Dial Transplant. 2022 Sep 14. pii: 6697766. doi: 10.1093.
    >> Share

  159. HIRANO K, Kobayashi D, Shimbo T, Komatsu Y, et al
    Impact of a continuous quality improvement program on contrast-induced nephropathy in outpatients with chronic kidney disease: an interrupted time-series study.
    Nephrol Dial Transplant. 2022 Sep 13. pii: 6696972. doi: 10.1093.
    >> Share

  160. BEURTON A, Fajardie A, Rubin S, Belnou P, et al
    Impact of previous REnal TRansplantation on the mid-term renal Outcome after CARdiac surgery: the RETROCAR trial.
    Nephrol Dial Transplant. 2022 Sep 13. pii: 6696971. doi: 10.1093.
    >> Share

  161. XIE D, Zhu Q, Lu J, Hu C, et al
    Development and validation of a diagnostic nomogram for sarcopenia in Chinese hemodialysis patients.
    Nephrol Dial Transplant. 2022 Sep 9. pii: 6695008. doi: 10.1093.
    >> Share

  162. MUREA M, Kalantar-Zadeh K
    Starting chronic hemodialysis twice-weekly: when less is more.
    Nephrol Dial Transplant. 2022 Sep 9. pii: 6695007. doi: 10.1093.
    >> Share

  163. FARINA-HERNANDEZ A, Marrero-Miranda D, Perez-Carreno E, De Vera-Gonzalez A, et al
    Pretransplant evaluation and the risk of glucose metabolic alterations after renal transplantation: a prospective study.
    Nephrol Dial Transplant. 2022 Sep 9. pii: 6695005. doi: 10.1093.
    >> Share

  164. GEORGIANOS PI, Tziatzios G, Roumeliotis S, Vaios V, et al
    Effect of angiotensin converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2022 Sep 7. pii: 6693715. doi: 10.1093.
    >> Share

  165. SORENSEN IMH, Bjergfelt SS, Hjortkjaer HO, Kofoed KF, et al
    Coronary and extra-coronary artery calcium scores as predictors of cardiovascular events and mortality in chronic kidney disease stages 1-5: a prospective cohort study.
    Nephrol Dial Transplant. 2022 Sep 6. pii: 6692954. doi: 10.1093.
    >> Share

    August 2022
  166. LOPES MB, Karaboyas A, Zhao J, Johnson DW, et al
    Association of single and serial measures of serum phosphorus with adverse outcomes in patients on peritoneal dialysis: results from the international PDOPPS.
    Nephrol Dial Transplant. 2022 Aug 27. pii: 6677977. doi: 10.1093.
    >> Share


  167. Correction to: Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
    Nephrol Dial Transplant. 2022 Aug 25. pii: 6675830. doi: 10.1093.
    >> Share

  168. BOUWMANS P, Brandts L, Hilbrands LB, Duivenvoorden R, et al
    The clinical frailty scale as a triage tool for ICU admission of dialysis patients with COVID-19 - An ERACODA analysis.
    Nephrol Dial Transplant. 2022 Aug 24. pii: 6674776. doi: 10.1093.
    >> Share

  169. COLOMBO MG, Forster C, Wallwiener S, Hassdenteufel K, et al
    Comorbidity, life-style factors and health care utilization in incident chronic kidney disease: Sex-specific analyses of claims data.
    Nephrol Dial Transplant. 2022 Aug 23. pii: 6674223. doi: 10.1093.
    >> Share

  170. KETTELER M, Bover J, Mazzaferro S
    Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s.
    Nephrol Dial Transplant. 2022 Aug 17. pii: 6670816. doi: 10.1093.
    >> Share

  171. VAN DER WILLIK EM, van Breda F, van Jaarsveld BC, van de Putte M, et al
    Validity and reliability of Patient-Reported Outcomes Measurement Information System (PROMIS(R)) using Computerized Adaptive Testing (CAT) in patients with advanced chronic kidney disease.
    Nephrol Dial Transplant. 2022 Aug 1. pii: 6652904. doi: 10.1093.
    >> Share

    July 2022
  172. COLLISTER D, Herrington G, Delgado L, Whitlock R, et al
    Patient views regarding cannabis use in chronic kidney disease and kidney failure: a survey study.
    Nephrol Dial Transplant. 2022 Jul 26. pii: 6650227. doi: 10.1093.
    >> Share

  173. DAUGIRDAS JT
    Comparison of measured vs. kinetic-model predicted phosphate removal during hemodialysis and hemodiafiltration.
    Nephrol Dial Transplant. 2022 Jul 23. pii: 6649217. doi: 10.1093.
    >> Share

  174. OKUTE Y, Shoji T, Shimomura N, Tsujimoto Y, et al
    Serum phosphate as an independent factor associated with cholesterol metabolism in patients undergoing hemodialysis: a cross-sectional analysis of the DREAM cohort.
    Nephrol Dial Transplant. 2022 Jul 23. pii: 6649216. doi: 10.1093.
    >> Share


  175. Correction to: MO409: GDF-15 is a Predictor of Mortality in Chronic Kidney Disease Patients With Covid-19 Infection.
    Nephrol Dial Transplant. 2022 Jul 15. pii: 6644904. doi: 10.1093.
    >> Share

  176. ASSIMON MM, Pun PH, Al-Khatib SM, Brookhart MA, et al
    The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
    Nephrol Dial Transplant. 2022 Jul 6. pii: 6632991. doi: 10.1093.
    >> Share

    June 2022
  177. ASHBY DR, Caplin B, Corbett RW, Asgari E, et al
    Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort study.
    Nephrol Dial Transplant. 2022 Jun 29. pii: 6620856. doi: 10.1093.
    >> Share

  178. NADER R, Zhen A, Angel-Korman A, Pavlovich SS, et al
    Predictors and outcomes of acute kidney injury during autologous stem cell transplantation in AL amyloidosis.
    Nephrol Dial Transplant. 2022;37:1281-1288.
    >> Share

  179. CARAVACA-FONTAN F, Diaz-Encarnacion M, Cabello V, Ariceta G, et al
    Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy.
    Nephrol Dial Transplant. 2022;37:1270-1280.
    >> Share

  180. JAQUES DA, Ponte B, Haidar F, Dufey A, et al
    Outcomes of incident patients treated with incremental haemodialysis as compared to standard haemodialysis and peritoneal dialysis.
    Nephrol Dial Transplant. 2022 Jun 22. pii: 6613182. doi: 10.1093.
    >> Share

  181. DEAK AT, Belic K, Meissl AM, Artinger K, et al
    Salivary potassium measured by genetically encoded potassium ion indicators as a surrogate for plasma potassium levels in hemodialysis patients - a proof-of-concept study.
    Nephrol Dial Transplant. 2022 Jun 14. pii: 6608365. doi: 10.1093.
    >> Share

  182. GREEN JB, Mottl AK, Bakris G, Heerspink HJL, et al
    Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using an UACR Endpoint study (CONFIDENCE).
    Nephrol Dial Transplant. 2022 Jun 14. pii: 6608366. doi: 10.1093.
    >> Share

  183. WORBOYS HM, Cooper NJ, Burton JO, Young HML, et al
    Measuring Quality of Life in Trials Including Patients on Hemodialysis: Methodological Issues Surrounding use of the Kidney Disease Quality of Life Questionnaire. A Systematic Review.
    Nephrol Dial Transplant. 2022 Jun 11. pii: 6605927. doi: 10.1093.
    >> Share

  184. JUNG CY, Yun HR, Park JT, Joo YS, et al
    Association of coronary artery calcium with adverse cardiovascular outcomes and death in patients with chronic kidney disease: results from the KNOW-CKD.
    Nephrol Dial Transplant. 2022 Jun 11. pii: 6605928. doi: 10.1093.
    >> Share

  185. NG JH, Izard S, Murakami N, Jhaveri KD, et al
    Outcomes of kidney transplantation in patients with myeloma and amyloidosis in the US.
    Nephrol Dial Transplant. 2022 Jun 10. pii: 6605285. doi: 10.1093.
    >> Share

  186. BROWN EA, Ekstrand A, Gallieni M, Gorrin MR, et al
    Availability of assisted peritoneal dialysis in Europe: call for increased and equal access.
    Nephrol Dial Transplant. 2022 Jun 7. pii: 6603817. doi: 10.1093.
    >> Share

    May 2022
  187. HOLDEN RM, Booth SL, Zimmerman D, Moist L, et al
    Inhibit progression of coronary artery calcification with vitamin k in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-centre, pilot trial.
    Nephrol Dial Transplant. 2022 May 31. pii: 6596294. doi: 10.1093.
    >> Share

  188. MANFREDINI F, D'arrigo G, Lamberti N, Torino C, et al
    The legacy effect of a home walking exercise program in kidney failure patients on dialysis.
    Nephrol Dial Transplant. 2022 May 31. pii: 6596293. doi: 10.1093.
    >> Share

  189. EINBINDER Y, Hornik-Lurie T, Cohen-Hagai K, Goldman S, et al
    Correction to: Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients.
    Nephrol Dial Transplant. 2022 May 26. pii: 6593853. doi: 10.1093.
    >> Share

  190. DE BORST MH
    A new era in cardio-renal risk management: overview of landmark papers published in NDT in 2021.
    Nephrol Dial Transplant. 2022;37:1003-1005.
    >> Share

  191. VERNOOIJ RWM, Bots ML, Strippoli GFM, Canaud B, et al
    CONVINCE in the context of existing evidence on haemodiafiltration.
    Nephrol Dial Transplant. 2022;37:1006-1013.
    >> Share

  192. WACRENIER S, Riou J, Jourdain P, Guibert F, et al
    Lymphopaenia at diagnosis of anti-neutrophil cytoplasmic antibody-vasculitis with renal involvement is correlated with severity and renal prognosis.
    Nephrol Dial Transplant. 2022;37:1078-1087.
    >> Share

  193. HEWAWASAM E, Davies CE, Gulyani A, Li Z, et al
    Factors influencing fertility rates in Australian women receiving kidney replacement therapy: analysis of linked Australia and New Zealand Dialysis and Transplant Registry and perinatal data over 22 years.
    Nephrol Dial Transplant. 2022;37:1152-1161.
    >> Share

  194. SCHMIEDER RE
    Renal denervation in patients with chronic kidney disease: current evidence and future perspectives.
    Nephrol Dial Transplant. 2022 May 25. pii: 6592154. doi: 10.1093.
    >> Share

  195. BACHLE H, Sekula P, Schlosser P, Steinbrenner I, et al
    Uromodulin and its association with urinary metabolites: the German Chronic Kidney Disease Study.
    Nephrol Dial Transplant. 2022 May 24. pii: 6591612. doi: 10.1093.
    >> Share

  196. TANAKA M, Mori K, Takahashi S, Higashiura Y, et al
    Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than does fatty liver or nonalcoholic fatty liver disease.
    Nephrol Dial Transplant. 2022 May 24. pii: 6591613. doi: 10.1093.
    >> Share

  197. TORRES PU, Troya MI, Dauvergne M, Bover J, et al
    Correction to: Independent effects of parathyroid hormone and phosphate levels on hard outcomes in non-dialysis patients: food for thought.
    Nephrol Dial Transplant. 2022 May 20. pii: 6589624. doi: 10.1093.
    >> Share

  198. ARIF Y, Wenziger C, Hsiung JT, Edward A, et al
    Association of serum potassium with decline in residual kidney function in incident hemodialysis patients.
    Nephrol Dial Transplant. 2022 May 13. pii: 6585673. doi: 10.1093.
    >> Share

  199. STEINBRENNER I, Sekula P, Kotsis F, von Cube M, et al
    Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study.
    Nephrol Dial Transplant. 2022 May 7. pii: 6582232. doi: 10.1093.
    >> Share

  200. WEN W, Portales-Castillo I, Seethapathy R, Krinsky S, et al
    Intravenous sodium thiosulphate for vascular calcification of hemodialysis patients - a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2022 May 6. pii: 6581606. doi: 10.1093.
    >> Share

    April 2022
  201. LEENEN E, Erger F, Altmuller J, Wenzel A, et al
    Alport syndrome and autosomal dominant tubulointerstitial kidney disease frequently underlie end stage renal disease of unknown origin - a single center analysis.
    Nephrol Dial Transplant. 2022 Apr 29. pii: 6575901. doi: 10.1093.
    >> Share

  202. DI MARIO F, Regolisti G, Maggiore U, Pacchiarini MC, et al
    Hypophosphatemia in critically ill patients undergoing Sustained Low-Efficiency Dialysis with standard dialysis solutions.
    Nephrol Dial Transplant. 2022 Apr 27. pii: 6575048. doi: 10.1093.
    >> Share

  203. BROWN M, Chou A, Li C, Farshid S, et al
    Survival, symptoms and hospitalisation of older patients with advanced CKD managed without dialysis.
    Nephrol Dial Transplant. 2022 Apr 19. pii: 6570719. doi: 10.1093.
    >> Share


  204. Correction to: Impact of pre-graft serology on risk of BKPyV infection post-renal transplantation.
    Nephrol Dial Transplant. 2022 Apr 19. pii: 6570888. doi: 10.1093.
    >> Share

  205. CASTELLI C, Foucher Y, Boucquemont J, Prezelin-Reydit M, et al
    Impact of kidney transplantation in obese candidates: a time-dependent propensity score matching study.
    Nephrol Dial Transplant. 2022 Apr 19. pii: 6570721. doi: 10.1093.
    >> Share

  206. CARAVACA-FONTAN F, Polanco N, Villacorta B, Buxeda A, et al
    Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation.
    Nephrol Dial Transplant. 2022 Apr 11. pii: 6566352. doi: 10.1093.
    >> Share

  207. FRIED L, Schmedt N, Folkerts K, Bowrin K, et al
    High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database.
    Nephrol Dial Transplant. 2022 Apr 7. pii: 6564744. doi: 10.1093.
    >> Share

  208. WUERZNER G, Pruijm M, Burnier M
    Defining intradialytic hypertension: the importance of measuring blood pressure accurately.
    Nephrol Dial Transplant. 2022 Apr 1. pii: 6562093. doi: 10.1093.
    >> Share

    March 2022
  209. MARKOSSIAN TW, Samra MK, Huisingh-Scheetz M, Wadhwa A, et al
    Framework to reduce frailty in hemodialysis patients.
    Nephrol Dial Transplant. 2022 Mar 28. pii: 6555042. doi: 10.1093.
    >> Share

  210. BATAILLE S, Dou L, Bartoli M, Sallee M, et al
    Mechanisms of myostatin and activin A accumulation in chronic kidney disease.
    Nephrol Dial Transplant. 2022 Mar 25. pii: 6554261. doi: 10.1093.
    >> Share

  211. REHNBERG J, Ludvigsson JF, Carrero JJ, Emilsson L, et al
    Cancer risk in patients with immunoglobulin A nephropathy: a Swedish population-based cohort study.
    Nephrol Dial Transplant. 2022;37:749-759.
    >> Share

  212. BRUNORI G, Aucella F
    Chosing the best renal care for our patients: the evolving landscape of dialysis therapy.
    Nephrol Dial Transplant. 2022;37:617-619.
    >> Share

  213. LUBETZKY M, Zhao Z, Sukhu A, Sharma V, et al
    Characteristics of natural immunity to SARS-CoV-2 over time in wait-listed dialysis patients and recent kidney transplant recipients.
    Nephrol Dial Transplant. 2022 Mar 22. pii: 6552145. doi: 10.1093.
    >> Share

  214. HAMANO T, Imaizumi T, Hasegawa T, Fujii N, et al
    Biopsy-proven CKD etiology and outcomes: Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
    Nephrol Dial Transplant. 2022 Mar 22. pii: 6552146. doi: 10.1093.
    >> Share

  215. YEE-MOON WA
    Comparing survival between home hemodialysis and peritoneal dialysis - is the controversy over?
    Nephrol Dial Transplant. 2022 Mar 15. pii: 6548903. doi: 10.1093.
    >> Share

  216. DE NICOLA L, Serra R, Provenzano M, Minutolo R, et al
    Risk of end stage kidney disease in kidney transplant recipients versus patients with native chronic kidney disease: multicenter unmatched and propensity-score matched analyses.
    Nephrol Dial Transplant. 2022 Mar 12. pii: 6547760. doi: 10.1093.
    >> Share

  217. COUCHOUD C, Bechade C, Kolko A, Baudoin AC, et al
    Dialysis-network variability in home dialysis use not explained by patient characteristics: a national registry-based cohort study in France.
    Nephrol Dial Transplant. 2022 Mar 7. pii: 6543724. doi: 10.1093.
    >> Share

  218. BRES E, Pagan C, Bouchara A, Pastural M, et al
    3-methylhistidine and clinical outcomes in maintenance hemodialysis patients.
    Nephrol Dial Transplant. 2022 Mar 2. pii: 6540981. doi: 10.1093.
    >> Share

    February 2022
  219. YAN P, Duan SB, Luo XQ, Zhang NY, et al
    Development and validation of a deep neural network-based model to predict acute kidney injury following intravenous administration of iodinated contrast media in hospitalized patients with chronic kidney disease: a multicohort analysis.
    Nephrol Dial Transplant. 2022 Feb 26. pii: 6537417. doi: 10.1093.
    >> Share

  220. LAVILLE SM, Couturier A, Lambert O, Metzger M, et al
    Urea levels and cardiovascular disease in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2022 Feb 26. pii: 6537416. doi: 10.1093.
    >> Share

  221. IMAMURA K, Yamamoto S, Suzuki Y, Yoshikoshi S, et al
    Comparison of the association between six different frailty scales and clinical events in patients on hemodialysis.
    Nephrol Dial Transplant. 2022 Feb 25. pii: 6536926. doi: 10.1093.
    >> Share

  222. PIZZARELLI F, Basile C
    Do we have to rely on metric-based quality improvement strategies for the management of ESKD?
    Nephrol Dial Transplant. 2022;37:397-399.
    >> Share

  223. DE JONG RW, Stel VS, Rahmel A, Murphy M, et al
    Patient-reported factors influencing the choice of their kidney replacement treatment modality.
    Nephrol Dial Transplant. 2022;37:477-488.
    >> Share

  224. VOOREND CGN, van Oevelen M, Verberne WR, van den Wittenboer ID, et al
    Survival of patients who opt for dialysis versus conservative care: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2022 Feb 23. pii: 6534933. doi: 10.1093.
    >> Share

  225. IMASAWA T, Saito C, Kai H, Iseki K, et al
    Long-term Effectiveness of a Primary Care Practice Facilitation Program for Chronic Kidney Disease Management: An Extended Follow-up of a Cluster-Randomized FROM-J Study.
    Nephrol Dial Transplant. 2022 Feb 23. pii: 6534934. doi: 10.1093.
    >> Share

  226. MANLEY HJ, Aweh G, Frament J, Ladik V, et al
    A real world comparison of HepB (Engerix-B(R)) and HepB-CpG (Heplisav-B(R)) vaccine seroprotection in patients receiving maintenance dialysis.
    Nephrol Dial Transplant. 2022 Feb 12. pii: 6527595. doi: 10.1093.
    >> Share

  227. LANO G, Sallee M, Pelletier M, Bataille S, et al
    Neutrophil:lymphocyte ratio correlates with the uremic toxin indoxyl sulfate and predicts the risk of death in patients on hemodialysis.
    Nephrol Dial Transplant. 2022 Feb 10. pii: 6526681. doi: 10.1093.
    >> Share

  228. BARRATT J, Andric B, Tataradze A, Schomig M, et al
    Erratum to: Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A phase 3, randomised, 6 open-label, active-controlled study (DOLOMITES).
    Nephrol Dial Transplant. 2022 Feb 10. pii: 6526678. doi: 10.1093.
    >> Share

  229. MEIJERS B, Goedgezelschap A, Peeters D, Van Der Veen A, et al
    Heterologous vs. homologous triple anti-COVID-19 vaccine regimens in patients on maintenance hemodialysis.
    Nephrol Dial Transplant. 2022 Feb 9. pii: 6524916. doi: 10.1093.
    >> Share

  230. TUNGSANGA S, Katavetin P, Panpetch W, Udompornpitak K, et al
    Lactobacillus rhamnosus L34 attenuates chronic kidney disease progression in 5/6 nephrectomy mouse model through the excretion of anti-inflammatory molecules.
    Nephrol Dial Transplant. 2022 Feb 9. pii: 6524921. doi: 10.1093.
    >> Share

  231. CHEN JHC, Brown MA, Jose M, Brennan F, et al
    Erratum to: Temporal changes and risk factors for death from early withdrawal within 12 months of dialysis initiation-a cohort study.
    Nephrol Dial Transplant. 2022 Feb 8. pii: 6524783. doi: 10.1093.
    >> Share

  232. PEPIN M, Ferreira AC, Arici M, Bachmann M, et al
    Erratum to: Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment.
    Nephrol Dial Transplant. 2022 Feb 8. pii: 6524784. doi: 10.1093.
    >> Share

  233. KOLLAND M, Riedl R, Bachler B, Ribitsch W, et al
    Decreased response to the mRNA anti-SARS-CoV-2 vaccine in hepatitis B vaccine non-responders and frail patients treated with peritoneal dialysis.
    Nephrol Dial Transplant. 2022 Feb 7. pii: 6523369. doi: 10.1093.
    >> Share

  234. BORRELLI S, Mallamaci F, Chiodini P, Garofalo C, et al
    Salt intake correlates with night systolic blood pressure in non-dialytic chronic kidney disease.
    Nephrol Dial Transplant. 2022 Feb 7. pii: 6523367. doi: 10.1093.
    >> Share

  235. LEENDERS NHJ, Bos C, Hoekstra T, Schurgers LJ, et al
    Dietary magnesium supplementation inhibits abdominal vascular calcification in an experimental animal model of chronic kidney disease.
    Nephrol Dial Transplant. 2022 Feb 3. pii: 6521456. doi: 10.1093.
    >> Share

  236. BOUDHABHAY I, Serris A, Servais A, Planas D, et al
    COVID-19 outbreak in vaccinated patients from a hemodialysis unit: antibody titers as a marker of protection from infection.
    Nephrol Dial Transplant. 2022 Feb 1. pii: 6519271. doi: 10.1093.
    >> Share

    January 2022
  237. KOHMER N, Rabenau HF, Ciesek S, Kramer BK, et al
    Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies.
    Nephrol Dial Transplant. 2022 Jan 31. pii: 6517745. doi: 10.1093.
    >> Share

  238. VAN DER WILLIK EM, Lengton R, Hemmelder MH, Hoogeveen EK, et al
    Itching in dialysis patients: impact on health-related quality of life and interactions with sleep problems and psychological symptoms - results from the RENINE/PROMs registry.
    Nephrol Dial Transplant. 2022 Jan 31. pii: 6517747. doi: 10.1093.
    >> Share

  239. LEES JS, Elyan BMP, Herrmann SM, Lang NN, et al
    The 'other' big complication: how chronic kidney disease impacts on cancer risks and outcomes.
    Nephrol Dial Transplant. 2022 Jan 28. pii: 6516942. doi: 10.1093.
    >> Share

  240. MARROQUIN MV, Sy J, Kleine CE, Oveyssi J, et al
    Association of pre-ESKD hyponatremia with post-ESKD outcomes among incident ESKD patients.
    Nephrol Dial Transplant. 2022;37:358-365.
    >> Share

  241. VIGGIANO D, Capasso G
    How much time does it take to get cognitive impairment in kidney disease?
    Nephrol Dial Transplant. 2022;37:203-204.
    >> Share

  242. GOUGEON F, Singh HK, Nickeleit V
    Renal comorbidities in collapsing variant focal segmental glomerulosclerosis: more than a coincidence?
    Nephrol Dial Transplant. 2022;37:311-317.
    >> Share

  243. SNOEK R, van Jaarsveld RH, Nguyen TQ, Peters EDJ, et al
    Genetics-first approach improves diagnostics of ESKD patients <50 years old.
    Nephrol Dial Transplant. 2022;37:349-357.
    >> Share

  244. HEMMELDER MH, Noordzij M, Vart P, Hilbrands LB, et al
    Recovery of dialysis patients with COVID-19: Health outcomes 3 months after diagnosis in ERACODA.
    Nephrol Dial Transplant. 2022 Jan 14. pii: 6507563. doi: 10.1093.
    >> Share

  245. ZHI R, Zhang XD, Hou Y, Jiang KW, et al
    RtNet: a deep hybrid neural networks for the identification of acute rejection and chronic allograft nephropathy after renal transplantation using multiparametric MRI.
    Nephrol Dial Transplant. 2022 Jan 10. pii: 6502368. doi: 10.1093.
    >> Share

    December 2021
  246. DANSIE KB, Davies CE, Morton RL, Hawley CM, et al
    The IDEAL trial in Australia and New Zealand: clinical and economic impact.
    Nephrol Dial Transplant. 2021;37:168-174.
    >> Share

  247. NELVEG-KRISTENSEN KE, Szpirt W, Carlson N, McClure M, et al
    Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study.
    Nephrol Dial Transplant. 2021;37:63-71.
    >> Share

  248. JAMES LJ, Wong G, Tong A, Craig JC, et al
    Patient preferences for cancer screening in chronic kidney disease: a best-worst scaling survey.
    Nephrol Dial Transplant. 2021 Dec 27. pii: 6484819. doi: 10.1093.
    >> Share

  249. DANNEVILLE I, Beaumier M, Chatelet V, Boyer A, et al
    Are sex differences in the outcome of peritoneal dialysis explained by nurse-assistance? A cohort study with data from the RDPLF.
    Nephrol Dial Transplant. 2021 Dec 10. pii: 6459211. doi: 10.1093.
    >> Share

  250. WIJTVLIET VPWM, Arien KK, Abrams S, Couttenye MM, et al
    mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?
    Nephrol Dial Transplant. 2021 Dec 9. pii: 6458368. doi: 10.1093.
    >> Share

  251. DE ALARCON R, Alburquerque-Gonzalez B, Fernandez-Valera A, Molina-Nunez M, et al
    Pharmacogenetic role of vitamin D-binding protein and vitamin D receptor polymorphisms in the treatment response of dialysis patients with secondary hyperparathyroidism.
    Nephrol Dial Transplant. 2021 Dec 9. pii: 6458371. doi: 10.1093.
    >> Share

  252. MOLNAR AO, Bota SE, Naylor K, Nash DM, et al
    Opioid prescribing practices in chronic kidney disease: a population-based cohort study.
    Nephrol Dial Transplant. 2021 Dec 9. pii: 6458366. doi: 10.1093.
    >> Share

  253. HALFON M, Bachelet D, Hanouna G, Dema B, et al
    CD62L on blood basophils: a first pre-treatment predictor of remission in severe lupus nephritis.
    Nephrol Dial Transplant. 2021;36:2256-2262.
    >> Share

  254. SCHAEFFNER E
    Smoothing transition to dialysis to improve early outcomes after dialysis initiation among old and frail adults - a narrative review.
    Nephrol Dial Transplant. 2021 Dec 1. pii: 6447544. doi: 10.1093.
    >> Share

    November 2021
  255. CHU NM, Hong J, Harasemiw O, Chen X, et al
    Chronic kidney disease, physical activity, and cognitive function in older adults- results from the National Health and Nutrition Examination Survey (2011-2014).
    Nephrol Dial Transplant. 2021 Nov 25. pii: 6440170. doi: 10.1093.
    >> Share

  256. WATSON EL, Baker LA, Wilkinson TJ, Gould DW, et al
    Inflammation and physical dysfunction: responses to moderate intensity exercise in chronic kidney disease.
    Nephrol Dial Transplant. 2021 Nov 22. pii: 6433197. doi: 10.1093.
    >> Share

  257. CHU C, Chen X, Hasan AA, Szakallova A, et al
    Angiopoietin-2 predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis.
    Nephrol Dial Transplant. 2021 Nov 18. pii: 6430873. doi: 10.1093.
    >> Share

  258. CAUSLAND FRM, Ravi KS, Curtis KA, Kibbelaar ZA, et al
    A randomized controlled trial of two dialysate sodium concentrations in hospitalized hemodialysis patients.
    Nephrol Dial Transplant. 2021 Nov 18. pii: 6430877. doi: 10.1093.
    >> Share

  259. STUMPF J, Klimova A, Mauer R, Steglich A, et al
    Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and hemodialysis patients using mRNA vaccines.
    Nephrol Dial Transplant. 2021 Nov 15. pii: 6428414. doi: 10.1093.
    >> Share

  260. EINBINDER Y, Hornik-Lurie T, Cohen-Hagai K, Goldman S, et al
    Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients.
    Nephrol Dial Transplant. 2021 Nov 12. pii: 6426118. doi: 10.1093.
    >> Share

  261. QUIROGA B, Soler MJ, Ortiz A, Vaquera SM, et al
    Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study.
    Nephrol Dial Transplant. 2021 Nov 12. pii: 6426121. doi: 10.1093.
    >> Share

  262. ONISCU GC, Abramowicz D, Bolignano D, Gandolfini I, et al
    Management of obesity in kidney transplant candidates and recipients: A clinical practice guideline by the Descartes working group of ERA.
    Nephrol Dial Transplant. 2021 Nov 12. pii: 6426119. doi: 10.1093.
    >> Share

  263. GOFFIN E, Candellier A, Vart P, Noordzij M, et al
    COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study.
    Nephrol Dial Transplant. 2021;36:2094-2105.
    >> Share

  264. MINUTOLO R, Gabbai FB, Agarwal R, Garofalo C, et al
    Sex difference in ambulatory blood pressure control associates with risk of ESKD and death in CKD patients receiving stable nephrology care.
    Nephrol Dial Transplant. 2021;36:2000-2007.
    >> Share

  265. HARDING JL, Morton JI, Shaw JE, Patzer RE, et al
    Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the United States and Australia.
    Nephrol Dial Transplant. 2021 Nov 1. pii: 6415215. doi: 10.1093.
    >> Share

    October 2021
  266. PEPIN M, Ferreira AC, Arici M, Bachman M, et al
    Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment.
    Nephrol Dial Transplant. 2021 Oct 31. pii: 6414898. doi: 10.1093.
    >> Share

  267. LIABEUF S, Pepin M, Franssen CFM, Viggiano D, et al
    Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?
    Nephrol Dial Transplant. 2021 Oct 31. pii: 6414896. doi: 10.1093.
    >> Share

  268. TORRES PU, Troya MI, Dauverge M, Bover J, et al
    Independent effects of parathyroid hormone and phosphate levels on hard outcomes in non-dialysis patients: food for thought.
    Nephrol Dial Transplant. 2021 Oct 28. pii: 6413562. doi: 10.1093.
    >> Share

  269. WAKASUGI M, Kazama JJ, Nitta K, Narita I, et al
    Smoking and risk of fractures requiring hospitalization in hemodialysis patients: a nationwide cohort study in Japan.
    Nephrol Dial Transplant. 2021 Oct 27. pii: 6412547. doi: 10.1093.
    >> Share

  270. ROBERT T, Lano G, Giot M, Fourie T, et al
    Humoral response after SARS-COV2 vaccination in patient undergoing maintenance hemodialysis: loss of immunity, third dose and non-responders.
    Nephrol Dial Transplant. 2021 Oct 13. pii: 6395319. doi: 10.1093.
    >> Share

  271. SANTOS-ARAUJO C, Veiga PM, Santos MJ, Santos L, et al
    Time-dependent evolution of IgG antibody levels after first and second dose of mRNA-based SARS-CoV-2 vaccination in hemodialysis patients: a multicenter study.
    Nephrol Dial Transplant. 2021 Oct 11. pii: 6388402. doi: 10.1093.
    >> Share

  272. NATAATMADJA M, Zhao J, McCullough K, Fuller DS, et al
    International peritoneal dialysis training practices and the risk of peritonitis.
    Nephrol Dial Transplant. 2021 Oct 11. pii: 6388401. doi: 10.1093.
    >> Share

  273. RAMBABOVA-BUSHLJETIK I, Metzger J, Siwy J, Dohcev S, et al
    Association of the chronic kidney disease urinary proteomic predictor CKD273 with clinical risk factors of graft failure in kidney allograft recipients.
    Nephrol Dial Transplant. 2021 Oct 11. pii: 6388403. doi: 10.1093.
    >> Share

  274. PAI AY, Sy J, Kim J, Kleine CE, et al
    Association of serum globulin with all-cause mortality in incident hemodialysis patients.
    Nephrol Dial Transplant. 2021 Oct 7. pii: 6383009. doi: 10.1093.
    >> Share

  275. NANO J, Schottker B, Lin JS, Huth C, et al
    Novel biomarkers of inflammation, kidney function and chronic kidney disease in the general population.
    Nephrol Dial Transplant. 2021 Oct 6. pii: 6382139. doi: 10.1093.
    >> Share

  276. CHEN JJ, Lee TH, Tu YK, Kuo G, et al
    Pharmacological and Nonpharmacological Treatments for Restless Legs Syndrome in End Stage Kidney Disease: A Systematic Review and Component Network Meta-Analysis.
    Nephrol Dial Transplant. 2021 Oct 6. pii: 6382141. doi: 10.1093.
    >> Share

  277. BUTLER CR, Johansen KL
    Beyond exercise: supporting a range of physical activity for people receiving dialysis.
    Nephrol Dial Transplant. 2021 Oct 5. pii: 6381710. doi: 10.1093.
    >> Share

  278. GREZE C, Pereira B, Boirie Y, Guy L, et al
    Impact of obesity in kidney transplantation: a prospective cohort study from French registries between 2008 and 2014.
    Nephrol Dial Transplant. 2021 Oct 5. pii: 6381714. doi: 10.1093.
    >> Share

  279. CHAN GC, Than WH, Kwan BC, Lai KB, et al
    Adipose expression of miR-130b and miR-17-5p with wasting, cardiovascular event and mortality in advanced chronic kidney disease patients.
    Nephrol Dial Transplant. 2021 Oct 2. pii: 6380496. doi: 10.1093.
    >> Share

    September 2021
  280. DOREILLE A, Godefroy R, Martzloff J, Delthombe C, et al
    French nationwide survey of undocumented ESRD migrant patient access to scheduled hemodialysis and kidney transplantation.
    Nephrol Dial Transplant. 2021 Sep 29. pii: 6377827. doi: 10.1093.
    >> Share

  281. DAKROUB F, Touze A, Sater FA, Fiore T, et al
    The impact of pre-graft serology on the risk of BKPyV infection post-renal transplantation.
    Nephrol Dial Transplant. 2021 Sep 29. pii: 6377830. doi: 10.1093.
    >> Share

  282. OBERBAUER R, Meyer TW
    Corrigendum to: Precision medicine in transplantation and hemodialysis.
    Nephrol Dial Transplant. 2021 Sep 27. pii: 6376040. doi: 10.1093.
    >> Share

  283. LOCATELLI F, Del Vecchio L
    Dialysis dose and mortality: where is the limit?
    Nephrol Dial Transplant. 2021 Sep 27. pii: 6375949. doi: 10.1093.
    >> Share

  284. SOUWEINE JS, Pasquier G, Kuster N, Rodriguez A, et al
    Dynapaenia and sarcopaenia in chronic haemodialysis patients: do muscle weakness and atrophy similarly influence poor outcome?
    Nephrol Dial Transplant. 2021;36:1908-1918.
    >> Share

    August 2021
  285. GRAMS ME, Surapaneni A, Appel LJ, Lash JP, et al
    Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort Study.
    Nephrol Dial Transplant. 2021;36:1685-1693.
    >> Share

    July 2021
  286. REACH P, Touzot M, Lombardi Y, Maheas C, et al
    Electrochemical skin conductance by Sudoscan(R): a new tool to predict intradialytic hypotension.
    Nephrol Dial Transplant. 2021;36:1511-1518.
    >> Share

  287. HOPPE B, Pellikka PA, Dehmel B, Banos A, et al
    Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study.
    Nephrol Dial Transplant. 2021;36:1464-1473.
    >> Share

  288. KHOU V, De La Mata NL, Morton RL, Kelly PJ, et al
    Cause of death for people with end-stage kidney disease withdrawing from treatment in Australia and New Zealand.
    Nephrol Dial Transplant. 2021;36:1527-1537.
    >> Share

  289. VERBERNE WR, van den Wittenboer ID, Voorend CGN, Abrahams AC, et al
    Health-related quality of life and symptoms of conservative care versus dialysis in patients with end-stage kidney disease: a systematic review.
    Nephrol Dial Transplant. 2021;36:1418-1433.
    >> Share

  290. TAWADA M, Ito Y, Banshodani M, Yamashita M, et al
    Vasculopathy plays an important role during the development and relapse of encapsulating peritoneal sclerosis with conventional peritoneal dialysis solutions.
    Nephrol Dial Transplant. 2021;36:1519-1526.
    >> Share

  291. PICKUP LC, Law JP, Townend JN, Ferro CJ, et al
    Sudden cardiac death in chronic renal disease: aetiology and risk reduction strategies.
    Nephrol Dial Transplant. 2021;36:1386-1388.
    >> Share

    June 2021
  292. TYE SC, Denig P, Heerspink HJL
    Precision medicine approaches for diabetic kidney disease: opportunities and challenges.
    Nephrol Dial Transplant. 2021;36.
    >> Share

  293. SEIKRIT C, Rauen T, Stamellou E, Floege J, et al
    Precision medicine in immunoglobulin A nephropathy: still a journey ahead.
    Nephrol Dial Transplant. 2021;36.
    >> Share

    May 2021
  294. YEUNG EK, Polkinghorne KR, Kerr PG
    Home and facility haemodialysis patients: a comparison of outcomes in a matched cohort.
    Nephrol Dial Transplant. 2021;36:1070-1077.
    >> Share

  295. MURPHY E, Burns A, Murtagh FEM, Rooshenas L, et al
    The Prepare for Kidney Care Study: prepare for renal dialysis versus responsive management in advanced chronic kidney disease.
    Nephrol Dial Transplant. 2021;36:975-982.
    >> Share

  296. OGATA H, Shimofurutani N, Okada T, Nagamoto H, et al
    Efficacy and safety of oral tolvaptan in patients undergoing hemodialysis: a Phase 2, double-blind, randomized, placebo-controlled trial.
    Nephrol Dial Transplant. 2021;36:1088-1097.
    >> Share

  297. LIN TY, Hung SC
    Association of subjective global assessment of nutritional status with gut microbiota in hemodialysis patients: a case-control study.
    Nephrol Dial Transplant. 2021;36:1104-1111.
    >> Share

    April 2021
  298. SISE ME, McQuaid T, Martin P
    Sofosbuvir-based hepatitis C therapies in patients with chronic and end-stage kidney disease.
    Nephrol Dial Transplant. 2021 Apr 12. pii: 6225011. doi: 10.1093.
    >> Share

    March 2021
  299. HORACE RW, Roberts M, Shireman TI, Merhi B, et al
    Remnant cholesterol is prospectively associated with CVD events and all-cause mortality in kidney transplant recipients: the FAVORIT study.
    Nephrol Dial Transplant. 2021 Mar 24. pii: 6184949. doi: 10.1093.
    >> Share

    November 2020
  300. MALYSZKO J, Basak G, Batko K, Capasso G, et al
    Haematological disorders following kidney transplantation.
    Nephrol Dial Transplant. 2020 Nov 5. pii: 5956379. doi: 10.1093.
    >> Share

    September 2020
  301. ETHIER I, Cho Y, Hawley C, Pascoe EM, et al
    Multicenter registry analysis comparing survival on home hemodialysis and kidney transplant recipients in Australia and New Zealand.
    Nephrol Dial Transplant. 2020 Sep 3. pii: 5900874. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016